The Scientist

» cancer and disease/medicine

Most Recent

image: Contributors

Contributors

By | February 1, 2016

Meet some of the people featured in the February 2016 issue of The Scientist.

0 Comments

image: Fungal Security Force

Fungal Security Force

By | February 1, 2016

In yew trees, Taxol-producing fungi function as an immune system to ward off pathogens.

0 Comments

image: Marriages of Opportunity

Marriages of Opportunity

By | February 1, 2016

New ideas for antibody-drug conjugate design

0 Comments

image: The Mycobiome

The Mycobiome

By | February 1, 2016

The largely overlooked resident fungal community plays a critical role in human health and disease.

10 Comments

image: Illuminating a Cancer’s Origins

Illuminating a Cancer’s Origins

By | February 1, 2016

Researchers have developed a technique to visualize the origin of melanoma in zebrafish, throwing light on a genetic switch for cancer.

0 Comments

image: Schizophrenia and the Synapse

Schizophrenia and the Synapse

By | January 27, 2016

Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.

5 Comments

image: Disease-Linked Genes Questioned

Disease-Linked Genes Questioned

By | January 6, 2016

Many patients with genetic variations linked to cardiac disorders do not exhibit any symptoms, raising concerns about the validity of incidental findings of genetic tests.

0 Comments

image: Updating the Polio Vaccine

Updating the Polio Vaccine

By | January 4, 2016

Researchers develop new attenuated viruses that could support the eradication effort.

1 Comment

image: Pluripotency Bots

Pluripotency Bots

By | January 1, 2016

A tour of efforts to automate the production and differentiation of induced pluripotent stem cells

0 Comments

image: Managing Methylation

Managing Methylation

By | January 1, 2016

A long noncoding RNA associated with DNA methylation has the power to regulate colon cancer growth in vitro.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech